Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-21 | Amended | $10,017,500 | Unknown | Equity Only | SEC link | |
| 2024-07-29 | Amended | $5,217,500 | $3,357,500 | Equity Only | 06b | SEC link |
| 2023-07-31 | Amended | $1,860,000 | $1,430,000 | Equity Only | 06b | SEC link |
| 2023-04-14 | New | $430,000 | $430,000 | Equity Only | 06b | SEC link |
| 2022-09-20 | New | $2,500,000 | $2,500,000 | Equity Only | 06c | SEC link |
| 2021-01-12 | Amended | $3,000,000 | $1,860,000 | Equity Only | 06b | SEC link |
| 2020-01-16 | Amended | $1,140,000 | $1,140,000 | Equity Only | 06b | SEC link |
| 2019-01-08 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2018-08-01 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
| 2017-09-01 | New | $250,000 | $250,000 | Equity Only | 06b | SEC link |
| 2016-05-19 | New | $200,000 | $200,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Erik Hermansen | Executive |
| Chaid Schwarz | Executive |
| Eric Solien | Executive |
| Andrea Sweeney | Executive |
| Manny Villafana | Director, Executive, Promoter |
| Jeff Vreeman | Executive |